Stock Price Quote

DOCTORS BIOTECH INDIA LTD.

NSE : NABSE : 512079ISIN CODE : INE739D01027Industry : ChemicalsHouse : Private
BSE3.960 (0 %)
PREV CLOSE ( ) 3.96
OPEN PRICE ( ) 4.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )3.53 4.24
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
- Chairman - Managing Director
Registered Office

Address 3-B, 76/78, Mody Street Sai Sadan Chambers Fort,
Mumbai,
Maharashtra-400001

Phone 022- 22619131

Email --

Website NA

Registrars Details
Sharex (India) Pvt Ltd
17/B Dena Bank Building , 2nd floor,Horniman Circle,Fort,Mumbai
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Dec 00 ANNUAL 00
Net Profit-0.14
Gross Profit 0.2
Operating Profit 0.22
Net Sales 0.29

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Atul (BSE)
peergroup  7381.35 (6.31%)
M.Cap ( in Cr)20878.33
Polson (BSE)
peergroup  14669.00 (1.97%)
M.Cap ( in Cr)176.03
Fine Organic Inds. (BSE)
peergroup  5285.00 (2.76%)
M.Cap ( in Cr)16127.15
Solar Industries (BSE)
peergroup  10985.55 (0.98%)
M.Cap ( in Cr)98804.73
Elantas Beck India (BSE)
peergroup  10988.95 (0.89%)
M.Cap ( in Cr)8684.54

Shareholding Pattern

No Data Found

About Doctors Biotech India Ltd.

Doctors Biotech India Ltd. was incorporated in the year 1984. Its today's share price is 3.96. Its current market capitalisation stands at Rs 3.96 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10.89 Cr and Total Income of Rs.10.89 Cr. The company's management includes Kiran Agarwal, Manish Agrawal, Mahesh Adsul.

It is listed on the BSE with a BSE Code of 512079 , NSE with an NSE Symbol of and ISIN of INE739D01027. It's Registered office is at 3-B, 76/78, Mody Street Sai Sadan Chambers FortMumbai-400001, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.